Erlotinib does not improve survival in glioblastoma multiforme
Oral agent suitable for previously treated non-small-cell lung cancer
Chemoradiotherapy feasible in breast cancer with brain metastases
Multimodality therapy can cure unresectable colorectal cancer
Calcium and vitamin D use does not prevent invasive breast cancer
Genetic markers predict residual tumor response to adjuvant chemotherapy
Sorafenib improves markers associated with survival in liver cancer